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Study Importance Questions 
 
What is already known about this subject? 
 Gene copy number of salivary amylase (AMY1) has been reported to be 
associated with BMI 
 Attempts to replicate the finding have led to inconsistent outcomes 
 The strength of AMY1/BMI association may be age-dependent 
 
What does your study add? 
 
Our study adds  
 Application to association tests and validation of new PRT methods to 
measure amylase copy numbers 
 A well-powered specific test of the hypothesis of age-dependent association 
between AMY1 copy number and BMI 
 An additional independent and well-powered test of the general hypothesis of 









In a 2014 publication, evidence was presented supporting association of body mass 
index (BMI) with copy number of the salivary amylase (AMY1) gene, with an 
unprecedented effect size of −0.15kg/m2 (SE 0.02) per copy of AMY1. Most well-
powered attempts to reproduce these findings have not been successful. However, 
because of different study designs, a significant association may still apply under 
restricted conditions, such as in particular age groups. We specifically tested BMI-
AMY1 association at different age points in the same individuals, using longitudinal 
BMI information from participants in the UK 1958 Birth Cohort study. 
Methods 
We measured AMY1 copy number by paralogue ratio tests (PRT) in genomic DNA 
and using array-CGH data. BMI data from 1958 Birth Cohort subjects were available 
from eight different age points between 7 and 50 years old.  
Results  
We found no evidence, even at nominal significance, for association of amylase 
gene copy number with BMI at any age point in approximately 1400 members of the 
1958 Birth Cohort, nor in 2835 people from two disease cohorts from the Wellcome 
Trust Case Control Consortium.  
Conclusions  
Our results do not support association between BMI and AMY1 copy number at any 





Obesity remains a critical public health problem in many populations, and numerous 
individual factors have been defined that contribute to the heritable component of 
variation in adiposity (most commonly represented by measurement of body mass 
index, BMI). In addition to relatively strong genetic factors, such as the well-
characterised variation in the gene FTO (1), GWAS analyses of very large cohort 
size have defined increasing numbers of single nucleotide polymorphism (SNP) loci 
associated with variation in BMI (2). 
By contrast with SNP diversity, gene copy number variation (CNV) poses practical 
difficulties for accurate measurement (3, 4), but may have strong functional 
consequences through gene dosage effects. Furthermore, while variation at most 
biallelic CNVs can be effectively captured in SNP data, SNPs often have very little 
predictive power for more complex multiallelic CNVs (4), so that direct typing of copy 
number is necessary for effective analysis of association. This extra dimension of 
variation was explored in an analysis of association between BMI and copy number 
of the AMY1 (salivary amylase) gene; array-CGH and real-time PCR methods were 
used to analyse AMY1 copy number in more than 6,000 adult subjects, 
demonstrating a significant association of low AMY1 copy number with increased 
BMI (5). The study used adults, and drew representative population samples from 
the Twins UK (N = 1479, median age 53y) and DESIR (N = 2137, median age 52y) 
cohorts. Taken at face value, this effect ( = −0.15kg/m2 per copy of AMY1) would 
easily be the most substantial heritable factor yet discovered in obesity.  
In nearly all studies with best power to replicate Falchi et al.’s core finding of 
population-wide association between BMI and AMY1 copy number (5), no significant 
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associations have been observed. However, because different studies use cohorts 
with different properties, and in some cases also test different hypotheses, it is 
unclear whether the proposed association may still apply in some contexts. A very 
well-powered study in three cohorts of European adults (6), totalling over 4,000 
individuals and including people selected for being at the extremes of the BMI 
distribution, strongly excluded a major effect in the general population.  
A study of AMY1 copy number in 4800 nondiabetic adult subjects did not replicate 
the simple association found by Falchi et al. between AMY1 CN and BMI (P=0.8) (7), 
but provided evidence for dependence of the relationship between AMY1 copy 
number and BMI on dietary starch intake. Plasma enzyme activity was significantly 
associated both with AMY1 gene copy number and with BMI in the well-
characterised DESIR cohort, but association between BMI and AMY1 copy number 
was only nominally significant (P=0.023) (8). In the same study, analysis of two 
further case-control cohorts for obesity, comparing 1179 affected adults with 2220 
controls, and 785 affected children and adolescents with 712 controls, found a 
significant association of obesity with AMY1 copy number (P = 6.8 x 10-3 overall), 
mostly driven by association (P = 7.1 x 10-3) among the children and adolescents (8). 
Studies specifically analysing obesity in children and young adults have yielded 
results apparently supporting the association of BMI with amylase copy number. A 
study comparing 293 Mexican children with obesity against 304 normal weight 
controls (mean age 9.5 years) found a highly significant association (9). Significant 
associations of AMY1 with BMI were reported in Finnish females (N = 29, P = 0.045) 
but not males among young adults (mean ages 19-20 years) affected by early-onset 
obesity (10) and in boys (P = 0.033) but not in girls among 744 Italian children with 
mean age 8.4 years (11). In contrast, no evidence for association was observed in 
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over 1000 Chinese and Malay males aged 18-21, in which AMY1 copy number was 
convincingly determined using droplet digital PCR (12). 
 
Taking all these studies together, the general population-wide association claimed by 
Falchi et al. is not supported by independent replication, but neither is an age-
restricted effect decisively excluded by all studies. Any genuine AMY1 association 
operating in specific, restricted contexts could still have great potential power in both 
understanding aetiology and in guiding specific interventions in clinical management. 
An effect of AMY1 variation on metabolism might be strongest at earlier ages, 
because of changes in carbohydrate intake and turnover during an individual’s 
lifetime. We particularly wanted to clarify the possible age-dependence of AMY1-BMI 
associations, and for this purpose we exploited the potential of the British 1958 Birth 
Cohort (National Child Development Study, (13)), determining AMY1 copy number 
both by direct measurement from genomic DNA and by custom analysis of existing 
array-CGH data. Samples from the 1958 Birth Cohort made up some of the 
unaffected control samples used in the Wellcome Trust Case-Control Consortium 
(WTCCC) studies (3, 14), from which CGH data were available. The 1958 Birth 
Cohort is a representative (unselected) population sample, and each 1958 Birth 
Cohort participant has multiple BMI measurements at intervals from birth to age 50, 






Subjects and DNA Samples  
The main association analyses described in this study used the subset of the UK 
1958 Birth Cohort included as control subjects in the WTCCC CNV analysis (3). The 
UK 1958 Birth Cohort study initially sampled 17416 children born in the UK in the 
same week in 1958, and data sweeps including interviews and biometric 
measurements were conducted at ages 7, 11, 16, 23, 33, 42, 44 and 50 (13). Loss to 
follow-up meant that by age 50 there were data from 9790 participants. DNA was 
prepared from immortalised cell lines derived from blood taken at age 44, and DNA 
and array CGH data were available for our study from 1448 people. The use of this 
cohort was therefore intended as a representative population sample, with no 
enrichment of people with extreme values. We also included two disease cohort 
samples from the WTCCC CNV study for which BMI, age and sex data were 
available as well as raw array-CGH data; these were 1027 samples (425 females) 
from the type II diabetes (T2D) cohort and 1808 samples (366 females) from the 
Coronary Artery Disease (CAD) cohort. All samples were from UK individuals; in the 
WTCCC CNV study, 26 individuals had been removed on the basis of Principal 
Component Analysis of genotypes, or of self-reported non-European ancestry (3). 
Recruitment, measurement and blood sampling of these cohorts were carried out 
with local ethical approval in the original studies. 
DNA samples from 1958 Birth Cohort participants were made available from the 
ALSPAC Laboratory, University of Bristol (under the management of Dr Sue Ring) 
after application to the METADAC Secretariat (at Bristol UK, subsequently 
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Newcastle, see https://www.metadac.ac.uk/1958bc/) and approval from the Access 
Committee for CLS Cohorts (ACCC, see http://www.cls.ioe.ac.uk/).   
BMI data  
Longitudinal BMI data for 1958 Birth Cohort participants were made available after 
approval from METADAC (see above); BMI was calculated as the mass in kg divided 
by the square of the height in metres, for which measurements had been recorded at 
age 7, 11, 16, 23, 33, 42, 44 and 50. Participants had a mean of 7.00 BMI 
measurements, and 90% of participants had at least 6 out of 8 possible BMI 
measurements; all age points had BMI data for at least 1100 people. BMI values 
(with corresponding age and sex information) for the WTCCC T2D and CAD cohorts 
were made available through the relevant WTCCC study leads (Andrew Hattersley 
[Exeter], Mark McCarthy [Oxford] and Will Rayner [Oxford] for T2D; Nilesh Samani 
[Leicester] and Alistair Hall [Leeds] for CAD). 
 
Array CGH data from WTCCC CNV study (including 1958BC, T2D and CAD cohorts)  
Raw array-CGH data generated as part of the WTCCC CNV study (3, 15) were 
made available by the European Genome-phenome Archive after application to the 
WTCCC Data Access Committee (cdac@sanger.ac.uk, see www.wtccc.org.uk/). 
Including controls and duplicates, genome-wide array data from 21058 DNA samples 
were available for analysis, including 1448 samples from the 1958 Birth Cohort.  
Copy number estimates for AMY2B were derived from raw array-CGH data by 
combining ratios (of quantile-normalised red:quantile normalised green) for the 10 
probes used in (15)  to define CNVR266.13, followed by probe variance scaling (3) 
and calibration to the known range of integer copy numbers. AMY2A copy number 
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was estimated from the ratio (of quantile-normalised red:quantile normalised green) 
for six probes in the region unique to AMY2A, followed by probe variance scaling, 
correction for cross-hybridization from AMY1, and integer calibration. Finally, copy 
number determination for AMY1 used the mean quantile-normalised ratio values for 
eight probes from the copy-variable AMY1 region; this initial estimate was further 
refined by a correction to remove the effect of cross-hybridization to other similar 
sequences (represented by seven probes) in the wider amylase gene region that did 
not bear a simple relationship to AMY1 copy number. Estimates of AMY1, AMY2A 
and AMY2B copy number derived by these methods showed the known properties of 
the variation, including predominance of even numbers for AMY1, and the parity for 
odd or even copy number between AMY1 and AMY2A (6, 16) (Figure 1a). 
PRT measurement of copy number in genomic DNA 
Measurement of copy number of AMY1, AMY2A and AMY2B in 1958 Birth Cohort 
genomic DNA samples followed the paralogue ratio test (PRT) methods described 
by Shwan et al. (17); in summary, AMY1 gene copy number was estimated after 
measurement of two AMY1AB:AMY1C ratios, and copy number estimates for 
AMY2A and AMY2B were deduced after measurement of the AMY2A/2B duplication 
sequence combined with measurement of the AMY2A:2B ratio as described (16, 17). 
Fluorescently labelled PCR products from these assays were combined and 
separated by electrophoresis in a single ABI3130xl capillary for each sample. Out of 
the 1448 samples tested, copy number measures were successfully obtained for 
AMY1 from 1308 samples, for AMY2A from 1300 samples and for AMY2B from 1309 
samples (Table S1). Amylase copy numbers derived from PRT analysis of genomic 
DNA from 1958 Birth Cohort samples have been submitted (in PLINK generic variant 




Association analysis and power calculations 
Analysis of association between BMI and amylase copy number was carried out 
using linear regression in the context of the PLINK toolset (v1.07) for genome-wide 
association studies (18). Amylase copy number was encoded in the generic variant 
(gvar) file format for multiallelic CNV; sex was included as a covariate, as was age, 
except in analysis of single age-points for 1958 Birth Cohort data. For analysis in 
children (ages 7, 11 and 16), we used BMI Z-scores relative to the mean and 
standard deviation of the cohort to examine association, but at older age points (age 
23+) BMI was used without transformation. The power of different cohorts was 
simulated using Monte-Carlo simulations (each with a million iterations) applying the 
effect size observed by Falchi et al. to the numbers of samples investigated in each 
cohort in this work. For the 1958 Birth Cohort samples, different numbers of 
individuals had both AMY1 copy number information and BMI data at different age 
points, but the minimum sample size (at age 16, N = 1107) has 58% power to 
demonstrate association significant at P = 0.01 and 78% power for P = 0.05; the 
mean number of informative 1958 Birth Cohort samples across the different age 
points (N = 1266) had 60% power to demonstrate association at P = 0.01, and 83% 
power for P = 0.05. For the WTCCC disease cohorts, 1808 CAD samples had 92% 
power, and 1027 T2D samples 76% power, to demonstrate association at nominal (P 
= 0.05) levels of significance. Finally, a combined cohort of 4237 adult samples had 
99.1% power to detect association significant at P = 0.01, and 99.9% power to detect 





Falchi et al.’s initial demonstration of association between BMI and AMY1 copy 
number mostly relied on real-time PCR typing of amylase copy number (5), and 
subsequent studies highlighted the apparently low accuracy of copy number 
measurement (6, 16). In seeking to replicate the association we therefore paid 
particular attention to accurate measurement of gene copy number for AMY1. We 
started with analysis of existing array CGH data for 20158 samples from the WTCCC 
CNV study, which included 1448 samples from the 1958 Birth Cohort (3). Variation in 
AMY1 gene number is complex at the sequence level, and presumably for this 
reason AMY1 variation was not among the copy-variable regions that could be called 
with high confidence in the WTCCC CNV study (3, 15). In this work, customised 
analysis of raw array-CGH data, informed by knowledge of the structural basis of the 
variation (6, 16), allowed us to extract measurements of AMY1 representation that 
clustered around integer values and matched the known properties of the variation 
(see Methods). The placement of clusters in Figure 1a demonstrates the known 
relationship between AMY1 and AMY2A copy number parity – when AMY2A has an 
odd number of copies, so does AMY1, and when AMY2A has an even number, so 
does AMY1 (6, 16). 
In parallel, we obtained independent duplicate copy number measurements by direct 
analysis of genomic DNA in 1448 DNA samples from the 1958 Birth Cohort, using 
ratio-based (Paralogue Ratio Test, PRT) methods (17), again demonstrating 
concordance with previous copy number distributions (Table S1) and the odd-even 
parity between AMY1 and AMY2A (Figure 1b). The mean copy numbers found in 
1958 Birth Cohort samples were 6.71 (range 2-15) for AMY1, 2.0 (range 0-5) for 
AMY2A and 2.15 (range 2-5) for AMY2B. Measurements of AMY1 copy number by 
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array-CGH and by PRT showed good agreement, with an r2 value of 0.872, and 90% 
of samples concordant for the inferred integer AMY1 copy number (Figure 1c). 
Similarly, both array-CGH and DNA typing methods were used to derive copy 
number estimates of the pancreatic amylase genes AMY2A and AMY2B (Figures 2a 
and 2b). Overall, the appearance of integer clusters, with a predominance of even 
copy numbers for AMY1 (6, 16), and demonstration of the known relationships 
between AMY1 and AMY2A gene copy numbers, provided validation of the accuracy 
of copy number estimates.  
We used linear regression with sex as a covariate to examine association between 
BMI (or BMI Z-score for ages 7, 11 and 16) and amylase gene copy number in the 
1958 Birth Cohort samples, at each of eight age points between ages 7 and 50 
(Table 1). Even at nominal levels of significance, no association was observed with 
copy number of AMY1, AMY2A or AMY2B, using either copy numbers measured by 
direct typing (Table 1) or from array-CGH (data not shown). To reduce the effects of 
error in copy number measurement, which might be most substantial at high copy 
numbers of AMY1, we also analysed association of BMI with AMY1 gene copy 
number after rounding to integer values conditional on AMY2A copy number: if 
AMY2A copy number was even, the measured AMY1 copy number was rounded to 
the nearest even number, and likewise for odd numbers. Again, no association of 
BMI with AMY1 was observed at any age point, even at nominal significance (data 
not shown). 
No significant association was observed (P > 0.05) when specifically testing the 
childhood data (from ages 7, 11 and 16) for association between AMY1 copy number 
and obesity as a categorical state (defining obesity as a BMI above the 95th centile, 
with controls below the 85th centile (9)). We also examined the trajectory of BMI with 
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age by testing the interaction between AMY1 copy number, BMI and age, detecting 
no significant interaction term (P = 0.27). 
We tested for associations specific to WTCCC disease cohorts, specifically 
hypothesising that type 2 diabetes (T2D) might be a state in which handling of 
dietary starch is more important for overall metabolism. BMI data were available for 
members of two of the WTCCC disease cohorts (type 2 diabetes [T2D] and 
Coronary Artery Disease [CAD]), and amylase gene copy numbers were estimated 
for these samples using the array-CGH analyses described in this work. Using sex 
and age as covariates, no significant associations were observed between BMI and 
amylase gene number in subjects with T2D or CAD (Table S2). Although use of the 
WTCCC disease cohorts may lead to bias and introduce heterogeneity into the 
populations studied, we combined data from different cohorts to get a single test of 
association with maximum power from the samples we had analysed. Combining 
T2D and CAD samples with the 1958 Birth Cohort samples gave a total of 4237 
individuals to test the simple hypothesis of association of BMI with amylase gene 
copy number. This analysis used sex and age as covariates, and a single age point 
(age 44) was chosen for the 1958 Birth Cohort. No significant association was 
observed between BMI and gene copy number for AMY1, AMY2A or AMY2B (P 







In attempting to replicate the observations of Falchi et al. (5) our data provide no 
support, even at nominal levels of significance, for association between BMI and 
amylase gene copy number at any age point in subjects from the 1958 Birth Cohort, 
or in the WTCCC T2D and CAD cohorts. In this respect our results are concordant 
with those of Usher et al. (6) and Yong et al. (12). Although we evaluated copy 
number directly by typing genomic DNA for only about 1300 samples from the 1958 
Birth Cohort (Table S1), all participants had array-CGH data available from the 
WTCCC CNV study, so that in practice power was limited by the availability of BMI 
data. In the sample from the UK 1958 Birth Cohort, different age points have 
different numbers of individuals with BMI data (from N=1107 at age 16 to N=1402 at 
age 44), and hence variable power to detect association at any one age point. At the 
most conservative extreme, if we assume that association of BMI with amylase gene 
copy number is only operating at a single age point in the 1958 Birth Cohort, then 
our study has between 78% and 86% power to detect association at nominal 
significance, assuming an effect of the magnitude claimed by Falchi et al 2014 (beta 
= −0.15kg/m2 per copy of AMY1). The results of Monte Carlo simulations of power at 
different individual age points are given in Table S3. These values offer conservative 
estimates of power, assuming that each individual age point is the only opportunity to 
detect association. Because in reality BMI at different age points for the same 
individual will not be independent, the overall power to test association in children 
might be conservatively estimated using the total number of unique individuals 
sampled at ages 7, 11 or 16 (N = 1406), which has more than 85% power to detect 
the full effect claimed by Falchi et al. at nominal significance (Table S3). If we could 
assume that the association applies equally and independently at all age points, then 
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effectively the longitudinal series of eight age points would create a very powerful 
resampling, increasing the power to nearly 100% to detect association at nominal 
significance in at least one of the age points. Furthermore, if the effect is age-
independent and unaffected by disease status, then our combined analysis of 4237 
independent samples also has close to 100% power to detect an effect of the 
magnitude reported by Falchi et al. (Table S3).  
Given the major role played by pancreatic amylase enzymes in intestinal digestion of 
dietary starch, it would be natural to predict that variation in the copy-variable 
pancreatic amylase (AMY2A/2B) genes could have a more substantial influence on 
carbohydrate metabolism than the salivary amylase genes. As part of these same 
analyses we were also able to derive copy number measurements for the pancreatic 
amylase genes AMY2A and AMY2B; no association was observed between BMI and 
the copy number of AMY2 genes, even at nominal levels of significance.  
The 1448 samples we studied from the UK 1958 Birth Cohort were used as controls 
in the WTCCC studies (3, 14), and were selected from the 9,790 participants still 
undergoing follow-up at age 50 from an original birth cohort of 17,406. It is not clear 
whether any bias may have been introduced alongside these reductions in 
participant numbers, and if so what influence such bias might have on our 
conclusions. Using all age points, our longitudinal analysis allowed us to address the 
question of whether AMY1 copy number might be associated with the pattern of BMI 
change with age, but again we were unable to demonstrate a significant association. 
Our study has the obvious limitation that BMI is the only phenotype analysed, with 
sex and (in some analyses) age as covariates; we have no information on potentially 
relevant environmental or lifestyle factors such as nutrition. An association 
conditional on lifestyle factors not recorded in our study, such as  dietary starch 
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intake (7), could therefore escape detection if the association could not be detected 
without allowance for this covariate. Indeed, the study of 4800 nondiabetic subjects 
with mean age 57y by Rukh et al. demonstrated no significant association of BMI 
with AMY1 copy number alone (P = 0.8), but found a significant interaction (P = 
0.007) conditional upon dietary starch intake. That study used droplet digital PCR to 
determine AMY1 copy number, and the excess of samples with even numbers of 
copies is reassuring that the accuracy of copy number determination is likely to be 
high. The use of the same individuals at different ages in our study provides a strong 
basis for evaluating age-dependent effects of AMY1 copy number on BMI, but 
suffers from a corresponding lack of constancy for environmental conditions; at 
earlier time points the subjects were younger, but they were also subject to different 
environmental conditions relevant to BMI, which have changed considerably during 
the lifetime of these individuals. 
 
Conclusions 
The original association claimed by Falchi et al. (5), which remains the largest study 
showing support for simple association of BMI with amylase copy number, had no 
conditional element other than correcting for age and sex as covariates. As a direct 
replication of the original findings of Falchi et al., the conclusions of our study remain 
unambiguously negative. In analysis of the 1958 Birth Cohort samples with age, we 
find no evidence to support an association between BMI and AMY1 copy number 
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Table 1 Association study between copy number estimates of AMY1, AMY2A or AMY2B measured directly by PRT methods, and 
BMI in the 1958 Birth Cohort samples, with sex as a covariate. *At ages 7, 11 and 16 association analysis used Z-scores, so that 
beta values are standardised (i.e., are measured in SDs per copy); at other ages BMI was used directly, so that the beta values 






AMY1 AMY2A  AMY2B 
Total Median BMI (1st-




Total Median BMI (1st-




Total Median BMI (1st-




7 1102 15.7 (14.9-16.7) -0.006 0.63 1096 15.7 (14.9-16.7) -0.004 0.94 1103 15.7 (14.9-16.7) 0.022 0.78 
11 1119 16.9 (15.8-18.4) 0.0066 0.62 1114 16.9 (15.8-18.4) -0.079        0.13 1120 16.9 (15.8-18.4) -0.051        0.52 
16 1035 20.1 (18.7-21.9) -0.001 0.91 1028 20.1 (18.6-21.9) 0.005 0.93 1032 20.1 (18.6-21.9) -0.043 0.612 
23 1144 22.2 (20.6-24.1) -0.023 0.57 1137 22.2 (20.6-24.1) -0.154 0.33 1142 22.2 (20.6-24.1) -0.208 0.38 
33 1203 24.3 (22.1-26.8) 0.023 0.67 1194 24.3 (22.1-26.8) -0.087 0.68 1201 24.3 (22.1-26.8) -0.504 0.11 
42 1257 25.3 (22.8-28.1) 0.135 0.49 1251 25.3 (22.9-28.1) 1.272 0.1 1258 25.3 (22.8-28.1) 1.461 0.21 
44 1266 26.7 (24.1-30) 0.008 0.89 1261 26.7 (24.1-30) 0.358 0.14 1268 26.7 (24.1-30) 0.17 0.64 












The relationship between measured AMY1 and AMY2A copy number in (a) array 
CGH data from 21058 samples from the WTCCC and (b) PRT data from 1287 
samples from the 1958 birth cohort. The inclusion in (a) of many WTCCC subjects 
not contributing to our BMI analysis illustrates the quality and uniformity of the 
WTCCC array CGH data we used, even at this high volume of throughput, with most 
individuals simply classifiable into discrete copy number classes for AMY1 and 
AMY2A. In (c), the concordance is shown for AMY1 copy numbers for 1308 samples 









Concordance of copy number measurements derived from array CGH and PRT for 
the copy numbers of (a) AMY2A in 1300 samples and (b) AMY2B in 1309 samples 
from the 1958 birth cohort. In (b), the PRT analysis infers a copy number of exactly 2 
from the absence of junction fragment products, so that over 1000 data points are 




Supporting Information (Tables S1-S3) 
 
Table S1. Observed integer copy number distributions among 1308 (AMY1), 1300 
(AMY2A) or 1309 (AMY2B) 1958 birth cohort participants, as measured from 
genomic DNA. In each entry the number of individuals observed in the integer copy 
number category is followed by the percentage population frequency in parentheses. 
copy number AMY1 AMY2A AMY2B 
0 0 (0%) 7 (0.54%) 0 (0%) 
1 0 (0%) 173 (13.31%) 0 (0%) 
2 22 (1.68%) 951 (73.15%) 1140 (87.09%) 
3 31 (2.37%) 158 (12.15%) 158 (12.07%) 
4 176 (13.46%) 10 (0.77%) 10 (0.76%) 
5 103 (7.87%) 1 (0.08%) 1 (0.08%) 
6 388 (29.66%) 0 (0%) 0 (0%) 
7 157 (12.00%) 0 (0%) 0 (0%) 
8 177 (13.53%) 0 (0%) 0 (0%) 
9 106 (8.10%) 0 (0%) 0 (0%) 
10 72 (5.50%) 0 (0%) 0 (0%) 
11 39 (2.98%) 0 (0%) 0 (0%) 
12 19 (1.45%) 0 (0%) 0 (0%) 
13 11 (0.84%) 0 (0%) 0 (0%) 
14 5 (0.38%) 0 (0%) 0 (0%) 
15 2 (0.15%) 0 (0%) 0 (0%) 
More 0 (0%) 0 (0%) 0 (0%) 







Table S2. Results of association analysis between array-CGH extracted copy 
number estimates of AMY1, AMY2A or AMY2B and BMI in type 2 diabetes (T2D) 
and coronary artery disease (CAD) cohorts. The analysis used linear regression, 
with sex and age as covariates.  
cohort samples trait AMY1 AMY2A AMY2B 
Beta p-value Beta p-value Beta p-value 
T2D 1027 BMI -0.06 0.44 -0.16 0.72 -0.16 0.72 






Table S3. Representative results of power simulations, showing the percentage 
power predicted from Monte Carlo simulations to detect association between BMI 
and AMY1 copy number at  = 0.01 or 0.05, with either the full effect size reported 
by Falchi et al. ( = −0.15kg/m2 per copy) or half this effect size. For the 1958 birth 
cohort BMI data are available from different numbers of people at different age 
points, so the first three rows show results using the least (age 16), average and 
greatest (age 44) numbers available. Among the children (ages 7, 11, 16) we 
simulated power assuming the total number of unique individuals for whom BMI data 
were available (N= 1406). One million iterations were used for each simulation. T2D 
= type II diabetes; CAD = coronary artery disease. 
 
N Subset Falchi et al. effect 
size 
Half effect size 
 = 0.01  = 0.05  = 0.01  = 0.05 
1107 1958 cohort age 16 53.8% 77.9% 13.6% 33.5% 
1266 1958 cohort mean  60.4% 82.5% 15.3% 36.6% 
1402 1958 cohort age 44 65.3% 85.7% 17% 39% 
1406 1958 cohort unique children 65.5% 85.8% 17% 39.1% 
1027 WTCCC T2D 50.7% 75.5% 12.7% 32.1% 
1808 WTCCC CAD 77.5% 92.3% 21.8% 46.1% 
4237 Combined 
1958BC+WTCCC cohorts 
99.1% 99.87% 50.9% 75.9% 
 
 
 
 
 
 
 
